The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
Stocks rose on Friday, but notched weekly losses as investors worried the U.S.-China trade war is hurting economic growth.US Marketsread more
The combination of mounting recession fears, bets on a more cautious Fed and a regular uptick in market volatility could spell more losses.Marketsread more
The therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy — a muscle-wasting disease and leading genetic cause of infant mortality, affecting 1 in every...Biotech and Pharmaceuticalsread more
SpaceX has raised just over $1 billion in financing since the beginning of the year.Investing in Spaceread more
An analyst for Ark Invest, which has a major investment in Tesla, says recent drastic price-target cuts by others on Wall Street are missing the big picture.Investingread more
A federal judge in California has blocked President Donald Trump from building sections of his long-sought border wall with money secured under his declaration of a national...Politicsread more
Former Foreign Minister Boris Johnson is seen as the bookmaker's favorite to succeed outgoing Prime Minister Theresa May.Europe Politicsread more
The race is underway to find a vaccine that can control African swine fever, a highly contagious and deadly viral infection ravaging China's hog population. There is currently...Agricultureread more
Apple bought Tueo Health, which was developing tech to help parents monitor asthma symptoms in children, using a mobile app and commercial breathing sensors.Technologyread more
Facebook shares will disappoint as governments increasingly scrutinize the company's practices, according to MoffettNathanson.
The firm lowered its rating to neutral from buy for Facebook shares, predicting the internet company will generate earnings below expectations this year.
"We believe that revenue growth deceleration coupled with the company's long-term margin guidance does not provide a meaningful near-term path for outperformance," analyst Michael Nathanson said in a note to clients Tuesday. "Facebook is increasingly under the eye of global politicians and regulators, which will force the company to become more aggressive on spending to show contrition. ... The deceleration in growth, coupled with continued regulatory scrutiny, is a toxic brew for any stock."
Facebook shares closed down 2.6 percent Tuesday.
Nathanson lowered his price target for Facebook shares to $175 from $200. The stock closed at $175.73 on Friday.
The analyst noted that the company gave lower operating profit margin guidance on its second-quarter earnings call. Facebook said the margin will fall to the "mid-30s on a percentage basis" over a multiyear period due to increased security and content review expenses. It reported a second-quarter operating margin of 44 percent.
"We do not see outsized performance on the horizon as Facebook's core platform is maturing and monetizing Stories may not be the runaway success needed in the near-term to pick up the slack," he said. "Further, expenses are expected to stay elevated as Facebook plays catch-up to secure and refresh its platform."
As a result, he reduced his Facebook 2019 earnings per share estimate to $7.90 from $8.25 versus the Wall Street consensus of $8.22.
Nathanson and the other co-founder of his firm, Craig Moffett, are widely watched analysts in the media and telecom space.
Facebook did not immediately respond to a request for comment.